Symbols / PIII $2.77 -0.36% P3 Health Partners Inc.
PIII Chart
About
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
Fundamentals
Scroll to Statements| Market Cap | 562.78M | Enterprise Value | 286.40M | Income | -147.95M | Sales | 1.46B | Book/sh | -47.24 | Cash/sh | 7.59 |
| Dividend Yield | — | Payout | 0.00% | Employees | 320 | IPO | — | P/E | — | Forward P/E | -13.19 |
| PEG | — | P/S | 0.39 | P/B | -0.06 | P/C | — | EV/EBITDA | -1.54 | EV/Sales | 0.20 |
| Quick Ratio | 0.22 | Current Ratio | 0.24 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -45.26 | EPS next Y | -0.21 |
| EPS Growth | — | Revenue Growth | 3.80% | Earnings | 2026-05-14 | ROA | -23.46% | ROE | -69.53% | ROIC | — |
| Gross Margin | -4.12% | Oper. Margin | -39.98% | Profit Margin | -10.14% | Shs Outstand | 3.29M | Shs Float | 1.41M | Short Float | 24.77% |
| Short Ratio | 0.79 | Short Interest | — | 52W High | 11.30 | 52W Low | 1.52 | Beta | 0.56 | Avg Volume | 88.06K |
| Volume | 10.29K | Target Price | $3.50 | Recom | None | Prev Close | $2.78 | Price | $2.77 | Change | -0.36% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-02 | main | TD Cowen | Hold → Hold | $3 |
| 2026-03-27 | main | Lake Street | Buy → Buy | $4 |
| 2025-11-17 | main | Lake Street | Buy → Buy | $13 |
| 2025-04-21 | main | Lake Street | Buy → Buy | $20 |
| 2024-11-20 | main | TD Cowen | Hold → Hold | $0 |
| 2024-04-01 | down | BTIG | Buy → Neutral | — |
| 2024-03-14 | main | Lake Street | Buy → Buy | $5 |
| 2023-09-01 | init | BTIG | — → Buy | $5 |
| 2023-06-30 | init | TD Cowen | — → Market Perform | — |
| 2022-01-04 | init | William Blair | — → Outperform | — |
- PIII P3 Health Partners Inc. reports far wider than expected Q4 2025 loss as shares rise 4 percent. - Dividend Growth - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 00
- P3 Health Partners (NASDAQ: PIII) asks shareholders to OK 3.34M warrant shares - Stock Titan Mon, 20 Apr 2026 20
- P3 Health (PIII) Macro Impact | Q4 2025: EPS Misses Views - Social Trade Signals - Xã Châu Thành hu, 23 Apr 2026 05
- How Recent Developments Are Reframing The P3 Health Partners (PIII) Investment Story - Yahoo Finance hu, 08 Jan 2026 08
- P3 Health (PIII) Stock: Is It Testing Levels (+0.77%) 2026-04-20 - Trending Stock Ideas - Xã Thanh Hà Mon, 20 Apr 2026 13
- P3 Health Partners (PIII) price target decreased by 61.90% to 4.08 - MSN ue, 21 Apr 2026 00
- P3 Health Partners Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis Sun, 21 Dec 2025 08
- P3 Health will post Q1 results May 14, then host a 4:30 p.m. ET call - Stock Titan hu, 16 Apr 2026 20
- What determines P3 Health (PIII) stock valuation (Investors Pile In) 2026-04-18 - Trending Social Stocks - Xã Châu Thành Sat, 18 Apr 2026 23
- Is P3 Health (PIII) Stock Testing Resistance | Price at $2.46, Down 4.28% - Verified Signals - UBND thành phố Hải Phòng Mon, 06 Apr 2026 07
- After a $323M annual loss, P3 Health targets positive EBITDA in 2026 - Stock Titan hu, 26 Mar 2026 07
- P3 Health (PIII) Stock: Is It Testing Levels (+0.77%) 2026-04-20 - Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 13
- Healthcare group P3 Health sets March 26 call on 2025 results - Stock Titan Fri, 13 Mar 2026 07
- P3 Health Partners shares drop more than 6% after weak outlook despite Q4 results beat - MSN ue, 07 Apr 2026 17
- P3 Health Partners (NASDAQ: PIII) deepens 2025 loss but guides to sharp EBITDA improvement in 2026 - Stock Titan hu, 26 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,459.08
-2.76%
|
1,500.45
+18.48%
|
1,266.38
+20.67%
|
1,049.47
|
| Operating Revenue |
|
1,428.98
-3.68%
|
1,483.60
+18.47%
|
1,252.31
+21.02%
|
1,034.80
|
| Operating Expense |
|
1,729.38
-4.62%
|
1,813.06
+26.41%
|
1,434.31
+10.72%
|
1,295.43
|
| Selling General And Administration |
|
107.23
-5.88%
|
113.93
-9.29%
|
125.59
-22.65%
|
162.38
|
| Selling And Marketing Expense |
|
0.92
-31.03%
|
1.33
-58.83%
|
3.23
-36.56%
|
5.10
|
| General And Administrative Expense |
|
106.31
-5.58%
|
112.60
-7.98%
|
122.36
-22.20%
|
157.28
|
| Other Gand A |
|
106.31
-5.58%
|
112.60
-7.98%
|
122.36
-22.20%
|
157.28
|
| Other Operating Expenses |
|
1,537.99
-4.65%
|
1,613.07
+32.00%
|
1,222.04
+16.86%
|
1,045.76
|
| Total Expenses |
|
1,729.38
-4.62%
|
1,813.06
+26.41%
|
1,434.31
+10.72%
|
1,295.43
|
| Operating Income |
|
-270.30
+13.53%
|
-312.60
-86.15%
|
-167.93
+31.72%
|
-245.96
|
| Total Operating Income As Reported |
|
-270.30
+15.70%
|
-320.66
-90.95%
|
-167.93
+89.24%
|
-1,560.91
|
| EBITDA |
|
-181.86
+8.04%
|
-197.76
-143.93%
|
-81.07
+94.45%
|
-1,461.00
|
| Normalized EBITDA |
|
-189.55
+15.79%
|
-225.09
-176.16%
|
-81.50
+47.73%
|
-155.91
|
| Reconciled Depreciation |
|
84.16
-2.20%
|
86.06
-0.71%
|
86.67
-0.70%
|
87.29
|
| EBIT |
|
-266.03
+6.27%
|
-283.82
-69.20%
|
-167.75
+89.17%
|
-1,548.29
|
| Total Unusual Items |
|
7.69
-71.86%
|
27.32
+6210.62%
|
0.43
+100.03%
|
-1,305.09
|
| Total Unusual Items Excluding Goodwill |
|
7.69
-71.86%
|
27.32
+6210.62%
|
0.43
+100.03%
|
-1,305.09
|
| Special Income Charges |
|
-0.16
-103.11%
|
5.21
|
0.00
+100.00%
|
-1,314.95
|
| Impairment Of Capital Assets |
|
—
|
—
|
0.00
-100.00%
|
1,314.95
|
| Write Off |
|
0.00
-100.00%
|
8.06
|
0.00
|
—
|
| Net Income |
|
-147.95
-8.91%
|
-135.85
-135.14%
|
-57.77
+78.61%
|
-270.13
|
| Pretax Income |
|
-321.06
-4.92%
|
-305.99
-66.54%
|
-183.73
+88.22%
|
-1,559.69
|
| Net Non Operating Interest Income Expense |
|
-55.03
-148.20%
|
-22.17
-38.71%
|
-15.98
-40.17%
|
-11.40
|
| Interest Expense Non Operating |
|
55.03
+148.20%
|
22.17
+38.71%
|
15.98
+40.17%
|
11.40
|
| Net Interest Income |
|
-55.03
-148.20%
|
-22.17
-38.71%
|
-15.98
-40.17%
|
-11.40
|
| Interest Expense |
|
55.03
+148.20%
|
22.17
+38.71%
|
15.98
+40.17%
|
11.40
|
| Other Income Expense |
|
4.27
-85.15%
|
28.78
+15542.39%
|
0.18
+100.01%
|
-1,302.33
|
| Other Non Operating Income Expenses |
|
-3.41
-334.32%
|
1.46
+685.14%
|
-0.25
-109.03%
|
2.76
|
| Gain On Sale Of Security |
|
7.85
-64.50%
|
22.11
+5007.16%
|
0.43
-95.61%
|
9.87
|
| Tax Provision |
|
2.02
-53.84%
|
4.39
+62.78%
|
2.69
+44.74%
|
1.86
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.61
-71.86%
|
5.74
+6210.62%
|
0.09
+100.03%
|
-274.07
|
| Net Income Including Noncontrolling Interests |
|
-323.09
-4.09%
|
-310.38
-66.49%
|
-186.43
+88.06%
|
-1,561.56
|
| Net Income From Continuing Operation Net Minority Interest |
|
-147.95
-8.91%
|
-135.85
-135.14%
|
-57.77
+78.61%
|
-270.13
|
| Net Income From Continuing And Discontinued Operation |
|
-147.95
-8.91%
|
-135.85
-135.14%
|
-57.77
+78.61%
|
-270.13
|
| Net Income Continuous Operations |
|
-323.09
-4.09%
|
-310.38
-66.49%
|
-186.43
+88.06%
|
-1,561.56
|
| Minority Interests |
|
175.14
+0.35%
|
174.53
+35.66%
|
128.65
-90.04%
|
1,291.43
|
| Normalized Income |
|
-154.02
+2.17%
|
-157.44
-170.90%
|
-58.12
-107.64%
|
760.89
|
| Net Income Common Stockholders |
|
-147.95
-8.91%
|
-135.85
-135.14%
|
-57.77
+78.61%
|
-270.13
|
| Diluted EPS |
|
-45.26
+16.19%
|
-54.00
-71.43%
|
-31.50
+90.31%
|
-325.00
|
| Basic EPS |
|
-45.26
+3.70%
|
-47.00
-54.10%
|
-30.50
+90.62%
|
-325.00
|
| Basic Average Shares |
|
3.27
+12.59%
|
2.90
+52.99%
|
1.90
+128.10%
|
0.83
|
| Diluted Average Shares |
|
3.27
+11.19%
|
2.94
-50.10%
|
5.89
+608.15%
|
0.83
|
| Diluted NI Availto Com Stockholders |
|
-147.95
+6.91%
|
-158.93
+14.75%
|
-186.43
+30.99%
|
-270.13
|
| Average Dilution Earnings |
|
0.00
+100.00%
|
-23.08
+82.06%
|
-128.65
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
84.16
-2.20%
|
86.06
-0.71%
|
86.67
-0.70%
|
87.29
|
| Depreciation And Amortization In Income Statement |
|
84.16
-2.20%
|
86.06
-0.71%
|
86.67
-0.70%
|
87.29
|
| Gain On Sale Of PPE |
|
-0.16
-101.22%
|
13.27
|
0.00
|
—
|
| Line Item | Trend | 2022-12-31 |
|---|---|---|
| Total Assets |
|
876.57
|
| Current Assets |
|
100.69
|
| Cash Cash Equivalents And Short Term Investments |
|
17.54
|
| Cash And Cash Equivalents |
|
17.54
|
| Cash Financial |
|
17.54
|
| Receivables |
|
79.59
|
| Accounts Receivable |
|
72.09
|
| Gross Accounts Receivable |
|
72.09
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
| Other Receivables |
|
7.50
|
| Prepaid Assets |
|
—
|
| Restricted Cash |
|
0.92
|
| Assets Held For Sale Current |
|
—
|
| Other Current Assets |
|
2.64
|
| Total Non Current Assets |
|
775.88
|
| Net PPE |
|
8.84
|
| Gross PPE |
|
11.46
|
| Accumulated Depreciation |
|
-2.62
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
5.09
|
| Construction In Progress |
|
3.46
|
| Other Properties |
|
1.10
|
| Leases |
|
1.81
|
| Goodwill And Other Intangible Assets |
|
751.05
|
| Goodwill |
|
0.00
|
| Other Intangible Assets |
|
751.05
|
| Other Non Current Assets |
|
15.99
|
| Total Liabilities Net Minority Interest |
|
353.91
|
| Current Liabilities |
|
241.66
|
| Payables And Accrued Expenses |
|
215.29
|
| Payables |
|
176.36
|
| Accounts Payable |
|
25.15
|
| Other Payable |
|
151.21
|
| Current Accrued Expenses |
|
38.93
|
| Current Debt And Capital Lease Obligation |
|
—
|
| Current Debt |
|
—
|
| Other Current Liabilities |
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
112.25
|
| Long Term Debt And Capital Lease Obligation |
|
105.94
|
| Long Term Debt |
|
94.42
|
| Long Term Capital Lease Obligation |
|
11.52
|
| Other Non Current Liabilities |
|
4.79
|
| Stockholders Equity |
|
5.85
|
| Common Stock Equity |
|
5.85
|
| Capital Stock |
|
0.02
|
| Common Stock |
|
0.02
|
| Share Issued |
|
0.83
|
| Ordinary Shares Number |
|
0.83
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
315.38
|
| Retained Earnings |
|
-309.55
|
| Minority Interest |
|
516.80
|
| Total Equity Gross Minority Interest |
|
522.66
|
| Total Capitalization |
|
100.28
|
| Working Capital |
|
-140.97
|
| Invested Capital |
|
100.28
|
| Total Debt |
|
105.94
|
| Net Debt |
|
76.88
|
| Capital Lease Obligations |
|
11.52
|
| Net Tangible Assets |
|
-745.20
|
| Tangible Book Value |
|
-745.20
|
| Current Provisions |
|
26.38
|
| Derivative Product Liabilities |
|
1.52
|
| Interest Payable |
|
14.06
|
| Non Current Note Receivables |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-91.24
+17.15%
|
-110.13
-44.85%
|
-76.03
+39.67%
|
-126.02
|
| Cash Flow From Continuing Operating Activities |
|
-91.24
+17.15%
|
-110.13
-44.85%
|
-76.03
+39.67%
|
-126.02
|
| Net Income From Continuing Operations |
|
-323.09
-4.09%
|
-310.38
-66.49%
|
-186.43
+88.06%
|
-1,561.56
|
| Depreciation Amortization Depletion |
|
84.16
-2.20%
|
86.06
-0.71%
|
86.67
-0.70%
|
87.29
|
| Depreciation And Amortization |
|
84.16
-2.20%
|
86.06
-0.71%
|
86.67
-0.70%
|
87.29
|
| Other Non Cash Items |
|
43.27
+1307.28%
|
3.08
+425.64%
|
0.58
+46.25%
|
0.40
|
| Stock Based Compensation |
|
5.58
-2.97%
|
5.75
-3.80%
|
5.98
-69.19%
|
19.40
|
| Provisionand Write Offof Assets |
|
21.75
-59.51%
|
53.70
+522.65%
|
-12.71
-10.85%
|
-11.46
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
8.06
|
0.00
-100.00%
|
1,314.95
|
| Deferred Tax |
|
2.87
+363.12%
|
-1.09
|
0.00
|
—
|
| Deferred Income Tax |
|
2.87
+363.12%
|
-1.09
|
0.00
|
—
|
| Operating Gains Losses |
|
-7.69
+78.27%
|
-35.38
-8071.59%
|
-0.43
+95.61%
|
-9.87
|
| Gain Loss On Investment Securities |
|
-7.85
+64.50%
|
-22.11
-5007.16%
|
-0.43
+95.61%
|
-9.87
|
| Change In Working Capital |
|
81.91
+2.28%
|
80.08
+164.32%
|
30.30
-12.99%
|
34.82
|
| Change In Receivables |
|
28.68
+1135.64%
|
-2.77
+93.41%
|
-41.99
-54.51%
|
-27.18
|
| Changes In Account Receivables |
|
—
|
—
|
4.56
+185.43%
|
-5.34
|
| Change In Prepaid Assets |
|
2.98
+127.53%
|
-10.83
-771.60%
|
-1.24
-129.14%
|
4.27
|
| Change In Payables And Accrued Expense |
|
55.43
-37.56%
|
88.77
+19.89%
|
74.04
+38.14%
|
53.60
|
| Change In Accrued Expense |
|
-2.65
-237.76%
|
-0.78
-107.94%
|
9.87
+36.88%
|
7.21
|
| Change In Payable |
|
58.07
-35.15%
|
89.55
+39.55%
|
64.17
+38.34%
|
46.39
|
| Change In Account Payable |
|
11.11
+237.12%
|
-8.10
-150.67%
|
15.99
+162.87%
|
6.08
|
| Change In Other Working Capital |
|
-2.30
-132.02%
|
-0.99
|
—
|
—
|
| Change In Other Current Assets |
|
-3.52
-8097.67%
|
-0.04
+25.86%
|
-0.06
-158.00%
|
0.10
|
| Change In Other Current Liabilities |
|
0.64
-89.23%
|
5.95
+1422.22%
|
-0.45
-111.16%
|
4.03
|
| Investing Cash Flow |
|
0.13
-99.11%
|
14.53
+895.02%
|
-1.83
+76.37%
|
-7.73
|
| Cash Flow From Continuing Investing Activities |
|
0.13
-99.11%
|
14.53
+895.02%
|
-1.83
+76.37%
|
-7.73
|
| Net PPE Purchase And Sale |
|
0.08
|
0.00
+100.00%
|
-1.83
+18.18%
|
-2.23
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-1.83
+18.18%
|
-2.23
|
| Sale Of PPE |
|
0.08
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
—
|
—
|
-1.83
+18.18%
|
-2.23
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-5.50
|
| Purchase Of Business |
|
—
|
—
|
0.00
+100.00%
|
-5.50
|
| Net Other Investing Changes |
|
0.05
-99.66%
|
14.53
|
—
|
—
|
| Financing Cash Flow |
|
72.81
-26.28%
|
98.77
-1.56%
|
100.33
+782.04%
|
11.38
|
| Cash Flow From Continuing Financing Activities |
|
72.81
-26.28%
|
98.77
-1.56%
|
100.33
+782.04%
|
11.38
|
| Net Issuance Payments Of Debt |
|
73.00
+23.82%
|
58.95
+318.09%
|
14.10
+23.96%
|
11.38
|
| Issuance Of Debt |
|
74.14
-17.56%
|
89.93
+537.74%
|
14.10
-5.99%
|
15.00
|
| Repayment Of Debt |
|
-1.14
+96.33%
|
-30.97
|
0.00
+100.00%
|
-3.62
|
| Long Term Debt Issuance |
|
73.00
-17.10%
|
88.06
+524.47%
|
14.10
-5.99%
|
15.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-0.05
|
| Net Long Term Debt Issuance |
|
73.00
-17.10%
|
88.06
+524.47%
|
14.10
-5.99%
|
15.00
|
| Short Term Debt Issuance |
|
1.14
-39.23%
|
1.87
|
0.00
|
0.00
|
| Short Term Debt Payments |
|
-1.14
+96.33%
|
-30.97
|
0.00
+100.00%
|
-3.62
|
| Net Short Term Debt Issuance |
|
0.00
+100.00%
|
-29.10
|
0.00
+100.00%
|
-3.62
|
| Net Common Stock Issuance |
|
—
|
—
|
86.59
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
40.50
-53.24%
|
86.59
|
—
|
| Net Other Financing Charges |
|
-0.19
+72.65%
|
-0.68
-86.81%
|
-0.36
|
—
|
| Changes In Cash |
|
-18.30
-677.49%
|
3.17
-85.91%
|
22.48
+118.37%
|
-122.38
|
| Beginning Cash Position |
|
44.10
+7.74%
|
40.93
+121.78%
|
18.46
-86.89%
|
140.83
|
| End Cash Position |
|
25.81
-41.48%
|
44.10
+7.74%
|
40.93
+121.78%
|
18.46
|
| Free Cash Flow |
|
-91.24
+17.15%
|
-110.13
-41.45%
|
-77.86
+39.30%
|
-128.25
|
| Interest Paid Supplemental Data |
|
13.64
-3.91%
|
14.19
+144.13%
|
5.81
+1.73%
|
5.71
|
| Income Tax Paid Supplemental Data |
|
1.44
-73.73%
|
5.48
+865.96%
|
0.57
|
0.00
|
| Change In Interest Payable |
|
-1.88
|
0.00
-100.00%
|
9.59
+81.23%
|
5.29
|
| Common Stock Issuance |
|
—
|
—
|
86.59
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
86.59
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-26 View
- 8-K2026-03-26 View
- 8-K2026-03-25 View
- 8-K2026-02-17 View
- 8-K2025-11-28 View
- 10-Q2025-11-14 View
- 8-K2025-11-14 View
- 8-K2025-11-14 View
- 8-K2025-08-29 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
- 42025-08-08 View
- 42025-08-08 View
- 42025-08-08 View
- 42025-08-08 View
- 42025-08-08 View
- 42025-08-08 View
- 42025-08-08 View
- 8-K2025-07-09 View
- 8-K2025-06-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|